The Global Oncology Clinical Trials Market is expected to grow from USD 8.43 billion in 2022 to USD 12.75 billion in 2032, representing a Compound Annual Growth Rate (CAGR) of 4.7%. The market growth is driven by factors such as an increasing incidence of cancer, rising demand for personalized medicine, and the need for novel and effective cancer treatments. The incidence of cancer worldwide...